Filing
Spy
Filing
Spy
Home
About
FNCH
Finch Therapeutics Group Inc
Clinical-stage biotechnology company developing microbiome therapies
CUSIP: 31773D200
Healthcare
US
1 holder
Ownership
Activity
2023 Q2
3 of 3 quarters
Total Value
$574.0K
Total Shares
67.3K
Net Share Change
+67.3K
Activity
1 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$574.0K
67.3K
0.0%
NEW
Baupost Group LLC
$574.0K
67.3K shares
NEW
FNCH — Finch Therapeutics Group Inc - FilingSpy